PortfoliosLab logoPortfoliosLab logo
RVMD vs. FCX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RVMD vs. FCX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Revolution Medicines, Inc. (RVMD) and Freeport-McMoRan Inc. (FCX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RVMD achieves a 108.17% return, which is significantly higher than FCX's 36.91% return.


RVMD

1D
1.73%
1M
9.40%
YTD
108.17%
6M
105.77%
1Y
318.08%
3Y*
86.60%
5Y*
38.23%
10Y*

FCX

1D
0.77%
1M
11.65%
YTD
36.91%
6M
37.31%
1Y
74.08%
3Y*
23.37%
5Y*
14.66%
10Y*
21.83%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RVMD vs. FCX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
RVMD
Revolution Medicines, Inc.
108.17%82.10%52.51%20.40%-5.36%-36.42%40.34%
FCX
Freeport-McMoRan Inc.
36.91%35.41%-9.41%13.69%-7.91%61.41%105.37%

Correlation

The correlation between RVMD and FCX is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.26

Correlation (3Y)
Calculated over the trailing 3-year period

0.25

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (All Time)
Calculated using the full available price history since Feb 13, 2020

0.26

Fundamentals

Market Cap

RVMD:

$32.85B

FCX:

$99.94B

EPS

RVMD:

-$7.17

FCX:

$1.89

PB Ratio

RVMD:

21.90

FCX:

5.12

Total Revenue (TTM)

RVMD:

$0.00

FCX:

$26.42B

Gross Profit (TTM)

RVMD:

-$4.70M

FCX:

$7.35B

EBITDA (TTM)

RVMD:

-$1.34B

FCX:

$9.59B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RVMD vs. FCX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RVMD
RVMD Risk / Return Rank: 9898
Overall Rank
RVMD Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
RVMD Sortino Ratio Rank: 9999
Sortino Ratio Rank
RVMD Omega Ratio Rank: 9898
Omega Ratio Rank
RVMD Calmar Ratio Rank: 9898
Calmar Ratio Rank
RVMD Martin Ratio Rank: 9898
Martin Ratio Rank

FCX
FCX Risk / Return Rank: 8080
Overall Rank
FCX Sharpe Ratio Rank: 8383
Sharpe Ratio Rank
FCX Sortino Ratio Rank: 7474
Sortino Ratio Rank
FCX Omega Ratio Rank: 7878
Omega Ratio Rank
FCX Calmar Ratio Rank: 8383
Calmar Ratio Rank
FCX Martin Ratio Rank: 8383
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RVMD vs. FCX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Revolution Medicines, Inc. (RVMD) and Freeport-McMoRan Inc. (FCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


RVMDFCXDifference
Sharpe ratioReturn per unit of total volatility

+3.25

Sortino ratioReturn per unit of downside risk

+3.92

Omega ratioGain probability vs. loss probability

1.82

1.27

+0.55

Calmar ratioReturn relative to maximum drawdown

12.84

2.99

+9.85

Martin ratioReturn relative to average drawdown

30.76

7.45

+23.31

RVMD vs. FCX - Sharpe Ratio Comparison

The current RVMD Sharpe Ratio is 4.77, which is higher than the FCX Sharpe Ratio of 1.53. The chart below compares the historical Sharpe Ratios of RVMD and FCX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

RVMD vs. FCX - Drawdown Comparison

The maximum RVMD drawdown since its inception was -73.29%, smaller than the maximum FCX drawdown of -92.52%. Use the drawdown chart below to compare losses from any high point for RVMD and FCX.


Loading charts...

Drawdown Indicators


RVMDFCXDifference

Max Drawdown

Largest peak-to-trough decline

-73.29%

-92.52%

+19.23%

Max Drawdown (1Y)

Largest decline over 1 year

-24.95%

-24.90%

-0.05%

Max Drawdown (3Y)

Largest decline over 3 years

-48.63%

-46.34%

-2.29%

Max Drawdown (5Y)

Largest decline over 5 years

-56.85%

-51.47%

-5.38%

Max Drawdown (10Y)

Largest decline over 10 years

-72.59%

Current Drawdown

Current decline from peak

0.00%

-3.50%

+3.50%

Average Drawdown

Average peak-to-trough decline

-35.58%

-39.59%

+4.01%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.40%

9.97%

+0.43%

Volatility

RVMD vs. FCX - Volatility Comparison

The current volatility for Revolution Medicines, Inc. (RVMD) is 14.01%, while Freeport-McMoRan Inc. (FCX) has a volatility of 16.04%. This indicates that RVMD experiences smaller price fluctuations and is considered to be less risky than FCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RVMDFCXDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.01%

16.04%

-2.03%

Volatility (6M)

Calculated over the trailing 6-month period

55.27%

37.47%

+17.80%

Volatility (1Y)

Calculated over the trailing 1-year period

67.30%

48.92%

+18.38%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

62.57%

45.04%

+17.53%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

65.69%

48.59%

+17.10%

Dividends

RVMD vs. FCX - Dividend Comparison

RVMD has not paid dividends to shareholders, while FCX's dividend yield for the trailing twelve months is around 0.87%.


PositionTTM20252024202320222021202020192018201720162015
FCX
Freeport-McMoRan Inc.
0.87%1.18%1.58%1.41%0.99%0.54%0.19%1.52%1.45%0.00%0.00%8.46%
RVMD
Revolution Medicines, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

RVMD vs. FCX - Financials Comparison

This section allows you to compare key financial metrics between Revolution Medicines, Inc. and Freeport-McMoRan Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B202220232024202520260
6.23B
(RVMD) Total Revenue
(FCX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


RVMD and FCX have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FCX has higher volatility (16.04%) compared to RVMD (14.01%). In terms of maximum drawdown, RVMD dropped -73.29% vs FCX's -92.52%.

RVMD currently has the higher Sharpe Ratio (4.77 vs 1.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RVMD and FCX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer